A survey found 93 percent and 70 percent of cancer centers are struggling with shortages of carboplatin and cisplatin, respectively, and while the FDA is trying to increase supply, hospitals are struggling to help patients.
Read the full post on Becker's Hospital Review - Healthcare News
